Elucidating Immunometabolic Responses to HIV Infection that Increase TB or HBV Risk (R01 Clinical Trial Not Allowed)
OpenUpdated: Oct 30, 2025
Summary
The grant aims to support research on how HIV-induced immunometabolic changes in individuals on combination antiretroviral therapy affect immune responses and increase the risk of poor outcomes from secondary infections like Mycobacterium tuberculosis and hepatitis B virus. Eligible applicants include various government entities, nonprofits, educational institutions, small businesses, and other organizations, including those serving specific communities and demographics. Application details are not provided in the description, but interested parties can contact NIH Grants Information for further inquiries.
Full Description
Description
Eligibility
Eligible applicants
Government
- County governments
- Federally recognized Native American tribal governments
- State governments
- Public and Indian housing authorities
- Special district governments
- City or township governments
Miscellaneous
- Other
Nonprofit
- Nonprofits non-higher education without 501(c)(3)
- Other Native American tribal organizations
- Nonprofits non-higher education with 501(c)(3)
Education
- Private institutions of higher education
- Public and state institutions of higher education
- Independent school districts
Business
- Small businesses
- For-profit organizations other than small businesses
Additional information
Grantor contact information
Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Recommended Resource
Grant Writing Services on Fiverr
Top PickStruggling with grant applications? Get expert help from professional freelance writers on Fiverr — from research and proposal drafts to compliance review and submission. Secure funding faster with proven talent.